SGP
SpyGlass Pharma, Inc. · Healthcare
Insiders bought $221.5M net in the last 90 days ·0 sellers, 15 buyers· latest Form 4 filed Feb 11, 2026
Insider Buying
$221.5M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
15
in the rolling window
Latest filing
Feb 11, 2026
Chang Carmen
SpyGlass Pharma, Inc. (SGP) has 15 SEC Form 4 filings (82 transaction rows) in the rolling window, disclosed by 15 distinct insiders. Most recent filing: Feb 11, 2026.
Inside the rolling window, 15 insiders at SpyGlass Pharma, Inc. reported 15 open-market purchases totaling $221.5M and no open-market sales. Insiders have net bought $221.5M over the trailing 6 months. The largest single insider purchase in this window was $59.0M by Director, 10% Owner RA CAPITAL MANAGEMENT, L.P. on Feb 9, 2026. The most recent open-market filing is a purchase of 937,500 shares by 10% Owner Chang Carmen, dated Feb 9, 2026, worth $15.0M.
- Industry:Biotechnology
- CEO:Patrick H. Mooney
- Employees:68
- HQ:Aliso Viejo, CA, US
- IPO:2026-02-06
| Source | |||||||
|---|---|---|---|---|---|---|---|
Chang CarmenFirst in 4 months | 10% Owner | Purchase | 937,500 | $15.0M | Feb 11 | — | SEC ↗ |
Florence Anthony A. Jr.First in 4 months | 10% Owner | Purchase | 937,500 | $15.0M | Feb 11 | — | SEC ↗ |
SANDELL SCOTT DFirst in 4 months | 10% Owner | Purchase | 937,500 | $15.0M | Feb 11 | — | SEC ↗ |
Walker Paul EdwardFirst in 4 months | 10% Owner | Purchase | 937,500 | $15.0M | Feb 11 | — | SEC ↗ |
Makhzoumi MohamadFirst filing | 10% Owner | Purchase | 937,500 | $15.0M | Feb 11 | — | SEC ↗ |
Yang RickFirst in 4 months | 10% Owner | Purchase | 937,500 | $15.0M | Feb 11 | — | SEC ↗ |
Behbahani AliFirst in 4 months | Director, 10% Owner | Purchase | 937,500 | $15.0M | Feb 11 | — | SEC ↗ |
BASKETT FORESTFirst in 4 months | 10% Owner | Purchase | 937,500 | $15.0M | Feb 11 | — | SEC ↗ |
New Enterprise Associates 17, L.P.First in 4 months | 10% Owner | Purchase | 937,500 | $15.0M | Feb 11 | — | SEC ↗ |
Mathers Edward TFirst in 4 months | 10% Owner | Purchase | 937,500 | $15.0M | Feb 11 | — | SEC ↗ |
| Director, 10% Owner | Purchase | 3,690,000 | $59.0M | Feb 11 | — | SEC ↗ | |
Pardo Geoffrey BFirst filing | Director | Purchase | 312,500 | $5.0M | Feb 11 | — | SEC ↗ |
Khan Bilal ArshadFirst filing | Director | Purchase | 135,000 | $2.2M | Feb 11 | — | SEC ↗ |
Vensana Capital I GP, LLCFirst filing | 10% Owner | Purchase | 165,000 | $2.6M | Feb 10 | — | SEC ↗ |
Nielsen Kirk G.First filing | Director | Purchase | 165,000 | $2.6M | Feb 10 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does SGP have?
SpyGlass Pharma, Inc. (SGP) has 15 SEC Form 4 filings (82 transaction rows) in the rolling 365-day window, disclosed by 15 distinct insiders. Most recent filing: Feb 11, 2026.
When was the most recent SEC Form 4 filing for SGP?
The most recent Form 4 filing for SGP on Tracefour is dated Feb 11, 2026.
What is the net insider flow at SGP over the last 6 months?
Over the trailing 180 days, insiders at SGP have net bought $221.5M based on SEC Form 4 disclosures.
What was the largest insider purchase at SGP?
The largest single insider open-market purchase at SGP in the rolling window was $59.0M by Director, 10% Owner RA CAPITAL MANAGEMENT, L.P. on 2026-02-09.
What is the total insider buy and sell value at SGP in the current window?
Inside the rolling window, insiders at SGP bought $221.5M and sold $0 based on SEC Form 4 filings.
Can I get alerts for SGP insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at SpyGlass Pharma, Inc. (SGP). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
SpyGlass Pharma, Inc. is in the Healthcare sector.